Coloplast A/S ADR | Cash Flow

Fiscal year is October-September. All values DKK Millions.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
3,672
3,147
1,535
4,096
5,024
5,091
Depreciation, Depletion & Amortization
488
426
485
528
611
625
Other Funds
773
160
924
2,722
978
933
Funds from Operations
3,387
3,413
2,944
1,902
4,657
4,783
Changes in Working Capital
251
264
393
1,126
1,406
422
Net Operating Cash Flow
3,136
3,149
3,337
3,028
3,251
4,361
Capital Expenditures
440
533
617
649
685
Sale of Fixed Assets & Businesses
11
8
49
16
36
Purchase/Sale of Investments
8
-
100
30
174
Net Investing Cash Flow
437
777
468
603
1,619
Cash Dividends Paid - Total
1,476
2,320
2,535
2,650
2,864
Issuance/Reduction of Debt, Net
1,417
-
-
122
1,136
Net Financing Cash Flow
3,430
2,898
2,963
2,746
1,854
Net Change in Cash
731
514
94
321
222
Free Cash Flow
2,727
2,644
2,754
2,401
2,590
Net Assets from Acquisitions
-
-
-
-
1,144
Change in Capital Stock
537
578
428
218
126
Exchange Rate Effect
-
12
-
-
-
Other Uses
-
252
-
-
-

About Coloplast A/S

View Profile
Address
Holtedam 1-3
Humlebæk ZE 3050
Denmark
Employees -
Website http://www.coloplast.com
Updated 07/08/2019
Coloplast A/S develops, manufactures, and markets medical products. It operates through the following segments: Chronic Care; Urology Care; and Wound and Skin Care. The Chronic Care segment covers the sale of ostomy care products and continence care products.